KBI Biopharma, Inc., a JSR Life Sciences company, established a new commercial manufacturing facility in Research Triangle Park, NC. KBI expects the $150 million, 140,000-sq.-ft. facility to be operational by 1Q22.
JSR Life Sciences, LLC is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA.
KBI Biopharma, a contract development and manufacturing organization (CDMO) and JSR Life Sciences affiliate company, has named Dirk Lange as president and chief executive office.